Cite
MLA Citation
Nobuaki Matsubara et al.. “Japanese subgroup analysis of EV‐301: An open‐label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma.” Cancer medicine, vol. 12, 2023, pp. 2761–2771. http://access.bl.uk/ark:/81055/vdc_100179401686.0x000013